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Background
Inflammation in the nasal mucosa has been shown to
correlate with the development of CRSwNP (chronic
rhinosinusitis with nasal polyps). The mechanism behind
this is not fully understood but changes in the activity of
the immune system might contribute to the growth of
polyps. The present study focuses on the potential role
of MHC II (major histocompatibility complex class II).
These cell surface proteins are of critical importance for
the function of cells in the immune system and poten-
tially in nasal polyp development.
Methods
Biopsies from polyps were obtained from patients with
CRSwNP (with and without local steroid treatment dur-
ing at least six consecutive weeks) as well as from the
mucosa (concha inferior) of healthy control subjects.
The obtained specimens were homogenized and subse-
quently analysed with flow cytometry.
Results
Preliminary data indicates a downregulation of MHC II
expression in polyp epithelial cells from patients with
CRSwNP compared to healthy patients (healthy con-
trols: 60,2±7,8; polyps 31,1±7,4; p <0,05). This reduction
seems to be independent of the steroid treatment. In
contrast, the level MHC II+/CD86+ on epithelial cells
was downregulated in patients receiving steroid treat-
ment but not in those without treatment. The mechan-
isms involved are presently investigated in mice.
Conclusion
Expression of MHC II and its co-receptor CD86 can be
seen on epithelial cells in the mucosa of healthy controls
as well as within the polyps of CRSwNP patients. This
suggests a role for epithelial cells in the antigen-present-
ing procedure. Change of the MHC II expression, alter-
ing the inflammatory activity in response to invading
microorganisms, might contribute to the development
of polyps.
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